Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 1:192:158-166.
doi: 10.1016/j.physbeh.2018.02.047. Epub 2018 Feb 24.

Timing of eating in adults across the weight spectrum: Metabolic factors and potential circadian mechanisms

Affiliations
Review

Timing of eating in adults across the weight spectrum: Metabolic factors and potential circadian mechanisms

Kelly C Allison et al. Physiol Behav. .

Abstract

Timing of eating is recognized as a significant contributor to body weight regulation. Disruption of sleep-wake cycles from a predominantly diurnal (daytime) to a delayed (evening) lifestyle leads to altered circadian rhythms and metabolic dysfunction. This article reviews current evidence for timed and delayed eating in individuals of normal weight and those with overweight or obesity: although some findings indicate a benefit of eating earlier in the daytime on weight and/or metabolic outcomes, results have not been uniformly consistent, and more rigorous and longer-duration studies are needed. We also review potential circadian mechanisms underlying the metabolic- and weight-related changes resulting from timed and delayed eating. Further identification of such mechanisms using deep phenotyping is required to determine targets for medical interventions for obesity and for prevention of metabolic syndrome and diabetes, and to inform clinical guidelines regarding eating schedules for management of weight and metabolic disease.

Keywords: Adipose; Circadian; Delayed eating; Gene expression; Metabolism; Weight.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Dr. Allison has research funding from Novo Nordisk and has been a consultant for Tanabe Mitsubishi Pharmaceuticals; these relationships do not directly relate to the contents of this article.

Similar articles

Cited by

References

    1. Ogden CL, Yanovski SD, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132:2087–2102. - PubMed
    1. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27. - PMC - PubMed
    1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–2291. - PMC - PubMed
    1. Bray GA. Risks of obesity. Endocrinol Metab Clin North Am. 2003;32:787–804. - PubMed
    1. Vairavamurthy J, Cheskin LJ, Kraitchman DL, Arepally A, Weiss CR. Current and cutting-edge interventions for the treatment of obese patients. Eur J Radiol. 2017;93:134–142. - PMC - PubMed

Publication types